Skip to content

CORNERSTONE THERAPEUTICS INC

CIK 0001145404

← back to feed
Revenue (TTM)
$169.61M
+14.5% YoY Q3 Oct 2013
Net Income (TTM)
$19M
−657.2% YoY Q3 Oct 2013
EPS Diluted (TTM)
$0.64
−620.0% YoY Q3 Oct 2013
Gross Margin
70.9%
Q3 Oct 2013
Operating Margin
20.1%
Q3 Oct 2013
Net Margin
11.2%
Q3 Oct 2013
Free Cash Flow (TTM)
$18.11M
Q3 Oct 2013
Cash
$69.61M
Q3 Oct 2013
Total Debt
$89.62M
Q3 Oct 2013
Shares Outstanding
26.9M sh
Q3 Oct 2013

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings